Description
Title: Rybelsus 3 – Oral GLP-1 Receptor Agonist for Type 2 Diabetes Management
Description: Rybelsus contains Semaglutide (3 mg), designed to help control blood sugar levels effectively in adults with type 2 diabetes through oral administration.
Contents: Semaglutide (3 mg)
Uses: Aids in managing elevated blood sugar levels alongside diet and exercise in adults with type 2 diabetes mellitus.
How It Works: Mimics GLP-1 hormone actions to enhance insulin secretion while suppressing glucagon release post-meals.
Side Effects: Common side effects may include nausea, vomiting, diarrhea, decreased appetite, and risk of hypoglycemia when combined with other antidiabetic medications.
Precautions: Consult a healthcare professional if you have a history of pancreatitis or kidney issues; monitor blood sugar regularly during treatment.
Directions for Use: Take orally once daily on an empty stomach at least thirty minutes before the first food or drink of the day; swallow whole without chewing.
There are no reviews yet.